Measurement of GABA using J-difference edited super(1)H-MRS following modulation of synaptic GABA concentration with tiagabine
Though GABA is the major inhibitory neurotransmitter in the brain, involved in a wide variety of brain functions and many neuropsychiatric disorders, its intracellular and metabolic presence provides uncertainty in the interpretation of the GABA signal measured by super(1)H-MRS. Previous studies dem...
Saved in:
Published in: | Synapse (New York, N.Y.) Vol. 68; no. 8; pp. 355 - 362 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
01-08-2014
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Though GABA is the major inhibitory neurotransmitter in the brain, involved in a wide variety of brain functions and many neuropsychiatric disorders, its intracellular and metabolic presence provides uncertainty in the interpretation of the GABA signal measured by super(1)H-MRS. Previous studies demonstrating the sensitivity of this technique to pharmacological manipulations of GABA have used nonspecific challenges that make it difficult to infer the exact source of the changes. In this study, the synaptic GABA reuptake inhibitor tiagabine, which selectively blocks GAT1, was used to test the sensitivity of J-difference edited super(1)H-MRS to changes in extracellular GABA concentrations. MEGA-PRESS was used to obtain GABA-edited spectra in 10 male individuals, before and after a 15-mg oral dose of tiagabine. In the three voxels measured, no significant changes were found in GABA+ concentration after the challenge compared to baseline. This dose of tiagabine is known to modulate synaptic GABA and neurotransmission through studies using other imaging modalities, and significant increases in self-reported sleepiness scales were observed. Therefore, it is concluded that recompartmentalization of GABA through transport block does not have a significant impact on total GABA concentration. Furthermore, it is likely that the majority of the magnetic resonance spectroscopy (MRS)-derived GABA signal is intracellular. It should be considered, in individual interpretation of GABA MRS studies, whether it is appropriate to attribute observed effects to changes in neurotransmission. Synapse 68:355-362, 2014. copyright 2014 Wiley Periodicals, Inc. Synaptic GABA uptake can be blocked using the GAT1 inhibitor tiagabine, to increase GABA concentrations in the synaptic cleft. J-difference edited MRS is useful for measuring brain GABA concentrations, but is shown here to be insensitive to these acute and transient changes in inhibitory signalling. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 23 ObjectType-Feature-1 |
ISSN: | 0887-4476 1098-2396 |
DOI: | 10.1002/syn.21747 |